A d-peptide-based oral nanotherapeutic modulates the PD-1/PD-L1 interaction for tumor immunotherapy

BackgroundPD-1/PD-L1 immune checkpoint inhibitors are currently the most commonly utilized agents in clinical practice, which elicit an immunostimulatory response to combat malignancies. However, all these inhibitors are currently administered via injection using antibody-based therapies, while ther...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Dan Liu, Jingmei Wang, Weiming You, Fang Ma, Qi Sun, Junjun She, Wangxiao He, Guang Yang
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Frontiers Media S.A. 2023-07-01
Cyfres:	Frontiers in Immunology
Pynciau:	immunotherapy peptide supramolecular nanospheres milk exosome anti-tumor
Mynediad Ar-lein:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1228581/full
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!